New drug shows promise for bulging eyes in small study
NCT ID NCT07085117
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 23 times
Summary
This study looked at how well the drug teprotumumab works for thyroid eye disease, a condition that can cause bulging eyes. It involved 5 people in China who received the drug. The main goal was to see if their eye bulging improved by at least 2 millimeters after treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID EYE DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Boao Vanguard Hospital
Qionghai, Hainan, 571400, China
Conditions
Explore the condition pages connected to this study.